Repeated mechanical thrombectomy for recurrent large vessel occlusion: A systematic review and meta-analysis

Author:

Elfil Mohamed1ORCID,Bahbah Eshak I2,Bayoumi Ahmed3,Aladawi Mohammad1,Eldokmak Mohamed4,Salem Mohamed M5,Aboutaleb Pakinam E6,Villafuerte-Trisolini Brian1,Al-Mufti Fawaz78ORCID,Ortega-Gutierrez Santiago91011ORCID,A Gonzalez-Castellon Marco1

Affiliation:

1. Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA

2. Faculty of Medicine, Al-Azhar University, Damietta, Egypt

3. McGovern Medical School, UT Houston, Houston, TX, USA

4. Department of Neurology, SUNY Downstate Health Sciences University, Brooklyn, NY, USA

5. Department of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, PA, USA

6. Department of Neurology, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, PA, USA

7. Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, NY, USA

8. Department of Neurology, Westchester Medical Center, New York Medical College, Valhalla, NY, USA

9. Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA

10. Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA

11. Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA

Abstract

Background Mechanical thrombectomy (MT) is the standard treatment for acute large vessel occlusion (LVO). Recurrent LVO can still occur in patients who already underwent MT for the first LVO. This study aimed to evaluate the efficacy of repeating MT for recurrent LVO. Methods This meta-analysis of the available literature was conducted to summarize the current evidence regarding repeated MT outcomes in patients with recurrent LVO. All studies with ≥ 1 outcomes of interest were included. The Newcastle-Ottawa Scale (NOS) was used for risk of bias assessment. Results Twenty studies, 10 observational (n = 21,251 patients) and 10 case reports (n = 10 patients), were included. 266 patients (62.78% females) with recurrent LVO were identified, with an overall prevalence of 1.6% and a mean age of 65.67 ± 16.23 years. Cardio-embolism was the most common mechanism in both times, with a median of 15 days between the first and second LVOs. Compared with pre-intervention, the first and second MTs significantly reduced the National Institute of Health Stroke Scale (NIHSS) score, (mean difference (MD) = −8.91) and (MD = −5.97) respectively, with a significant difference (p = 0.001). The rate of favorable outcome (modified Rankin scale (mRS) score 0–3) was 82.6% and 59.2% after the first and second MTs respectively, with a significant difference (p < 0.001). Conclusion In properly selected recurrent LVO patients, repeated MT is efficacious and safe. A prior MT procedure should not discourage aggressive treatment as many patients may achieve favorable outcomes.

Publisher

SAGE Publications

Subject

Immunology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3